Total Number of Communication Reports: 0
Monthly communication reports in the last 6 months: 0
End date of the last completed financial year: 2023-05-31
Government Institution | Funding Received in Last Financial Year | Funding Expected in Current Financial Year |
---|---|---|
Investissement Québec | $94,719.38 | Yes |
Address:
6111 Royalmount avenue, suite 100
Montreal, QC H4P 2T4
Canada
Telephone number:
514-340-9800
Web address:
https://www.pharmascience.com
Martin Arès, Chief Executive Officer
Pharmascience Inc. / Pharmascience Inc. is not a coalition.
The activities of Pharmascience Inc. / Pharmascience Inc. are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
Pharmascience Inc. / Pharmascience Inc. does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
Delaney Cullinan | No public offices held
Firm: Earnscliffe Strategy Group